speb/financial-data huggingface dataset:
MBIO income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -762000.00
MBIO income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -762000.00
MBIO cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -762000.00
MBIO income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -762000.00
MBIO income_statement (quarterly, 2025-06-30) — Net Interest Income: 123000.00
MBIO income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: 123000.00
MBIO balance_sheet (quarterly, 2025-06-30) — Net PPE: 0.00
MBIO cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: 0.00
MBIO balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 2892000.00
MBIO balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 150000.00
MBIO balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Revenue: 150000.00
MBIO income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -885000.00
MBIO income_statement (quarterly, 2025-06-30) — Normalized Income: -762000.00
MBIO cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -1339000.00
MBIO income_statement (quarterly, 2025-06-30) — Operating Income: -885000.00
MBIO income_statement (quarterly, 2025-06-30) — Operating Revenue: 0.00
MBIO balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 4377837.00
MBIO balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 172000.00
MBIO income_statement (quarterly, 2025-06-30) — Other Gand A: 787000.00
MBIO cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: -95000.00
MBIO balance_sheet (quarterly, 2025-06-30) — Other Receivables: 217000.00
MBIO balance_sheet (quarterly, 2025-06-30) — Payables: 8154000.00
MBIO balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 9932000.00
MBIO balance_sheet (quarterly, 2025-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 72000.00
MBIO balance_sheet (quarterly, 2025-06-30) — Preferred Shares Number: 250000.00
MBIO balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 0.00
MBIO income_statement (quarterly, 2025-06-30) — Pretax Income: -762000.00
MBIO cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 0.00
MBIO balance_sheet (quarterly, 2025-06-30) — Receivables: 217000.00
MBIO income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 0.00
MBIO income_statement (quarterly, 2025-06-30) — Research And Development: 98000.00
MBIO balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -397638000.00
MBIO cash_flow (quarterly, 2025-06-30) — Sale Of PPE: 0.00
MBIO income_statement (quarterly, 2025-06-30) — Selling General And Administration: 787000.00
MBIO balance_sheet (quarterly, 2025-06-30) — Share Issued: 4377837.00
MBIO income_statement (quarterly, 2025-06-30) — Special Income Charges: 0.00
MBIO cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 45000.00
MBIO balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 2892000.00
MBIO balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 2892000.00
MBIO income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
MBIO income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.00
MBIO balance_sheet (quarterly, 2025-06-30) — Total Assets: 13046000.00
MBIO balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 2892000.00
MBIO balance_sheet (quarterly, 2025-06-30) — Total Debt: 0.00
MBIO balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 2892000.00
MBIO income_statement (quarterly, 2025-06-30) — Total Expenses: 885000.00
MBIO balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 10154000.00
MBIO balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 0.00
MBIO balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 150000.00
MBIO income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: -885000.00
MBIO income_statement (quarterly, 2025-06-30) — Total Unusual Items: 0.00
MBIO income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 0.00
MBIO balance_sheet (quarterly, 2025-06-30) — Working Capital: 3042000.00
MBIO income_statement (quarterly, 2025-09-30) — +Operating Expense: 624000.00
MBIO income_statement (quarterly, 2025-09-30) — +Total Revenue: 0.00
MBIO balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 4993000.00
MBIO balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 407876000.00
MBIO cash_flow (quarterly, 2025-09-30) — Asset Impairment Charge: 0.00
MBIO balance_sheet (quarterly, 2025-09-30) — Assets Held For Sale Current: 0.00
MBIO income_statement (quarterly, 2025-09-30) — Basic Average Shares: 6241658.00
MBIO income_statement (quarterly, 2025-09-30) — Basic EPS: -0.07
MBIO cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 12657000.00
MBIO balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 0.00
MBIO balance_sheet (quarterly, 2025-09-30) — Capital Stock: 1000.00
MBIO balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 18984000.00
MBIO balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 18984000.00
MBIO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 7145000.00
MBIO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: 0.00
MBIO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -818000.00
MBIO cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: 0.00
MBIO cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 13000.00
MBIO cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: 12000.00
MBIO cash_flow (quarterly, 2025-09-30) — Change In Receivables: 0.00
MBIO cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 25000.00
MBIO cash_flow (quarterly, 2025-09-30) — Changes In Cash: 6327000.00
MBIO balance_sheet (quarterly, 2025-09-30) — Common Stock: 1000.00
MBIO balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 9771000.00
MBIO cash_flow (quarterly, 2025-09-30) — Common Stock Issuance: 0.00
MBIO balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 1826000.00
MBIO balance_sheet (quarterly, 2025-09-30) — Current Assets: 19361000.00
MBIO balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 0.00
MBIO balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 9440000.00
MBIO cash_flow (quarterly, 2025-09-30) — Depreciation: 0.00
MBIO cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 0.00
MBIO cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 0.00
MBIO income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 6241658.00
MBIO income_statement (quarterly, 2025-09-30) — Diluted EPS: -0.07
MBIO income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -468000.00
MBIO balance_sheet (quarterly, 2025-09-30) — Dueto Related Parties Current: 2529000.00
MBIO income_statement (quarterly, 2025-09-30) — EBIT: -624000.00
MBIO income_statement (quarterly, 2025-09-30) — EBITDA: -624000.00
MBIO cash_flow (quarterly, 2025-09-30) — End Cash Position: 18984000.00
MBIO cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 7145000.00
MBIO cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -818000.00
MBIO cash_flow (quarterly, 2025-09-30) — Gain Loss On Sale Of PPE: 0.00
MBIO income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 957000.00
MBIO balance_sheet (quarterly, 2025-09-30) — Gross PPE: 0.00
MBIO income_statement (quarterly, 2025-09-30) — Impairment Of Capital Assets: 0.00
MBIO income_statement (quarterly, 2025-09-30) — Interest Income: 156000.00
MBIO income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 156000.00
MBIO balance_sheet (quarterly, 2025-09-30) — Invested Capital: 9771000.00
MBIO cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: 0.00
MBIO cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: 0.00
MBIO balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 0.00
MBIO balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 0.00
MBIO cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 0.00
MBIO income_statement (quarterly, 2025-09-30) — Net Income: -468000.00
MBIO income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -468000.00
MBIO income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -468000.00
MBIO income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -468000.00
MBIO income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -468000.00
MBIO cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -468000.00
MBIO income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -468000.00
MBIO income_statement (quarterly, 2025-09-30) — Net Interest Income: 156000.00
MBIO income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: 156000.00
MBIO balance_sheet (quarterly, 2025-09-30) — Net PPE: 0.00
MBIO cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: 0.00
MBIO balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 9771000.00
MBIO balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 150000.00
MBIO balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Revenue: 150000.00
MBIO income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -624000.00
MBIO income_statement (quarterly, 2025-09-30) — Normalized Income: -468000.00
MBIO cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -818000.00
MBIO income_statement (quarterly, 2025-09-30) — Operating Income: -624000.00
MBIO income_statement (quarterly, 2025-09-30) — Operating Revenue: 0.00
MBIO balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 7299086.00
MBIO balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 160000.00
MBIO income_statement (quarterly, 2025-09-30) — Other Gand A: 957000.00
MBIO cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: -398000.00
MBIO balance_sheet (quarterly, 2025-09-30) — Other Receivables: 217000.00
MBIO balance_sheet (quarterly, 2025-09-30) — Payables: 7522000.00
MBIO balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 9348000.00
MBIO balance_sheet (quarterly, 2025-09-30) — Pensionand Other Post Retirement Benefit Plans Current: 92000.00
MBIO balance_sheet (quarterly, 2025-09-30) — Preferred Shares Number: 250000.00
MBIO balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 0.00
MBIO income_statement (quarterly, 2025-09-30) — Pretax Income: -468000.00
MBIO cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 7145000.00
MBIO balance_sheet (quarterly, 2025-09-30) — Receivables: 217000.00
MBIO income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 0.00
MBIO income_statement (quarterly, 2025-09-30) — Research And Development: -333000.00
MBIO balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -398106000.00
MBIO cash_flow (quarterly, 2025-09-30) — Sale Of PPE: 0.00
MBIO income_statement (quarterly, 2025-09-30) — Selling General And Administration: 957000.00
MBIO balance_sheet (quarterly, 2025-09-30) — Share Issued: 7299086.00
MBIO income_statement (quarterly, 2025-09-30) — Special Income Charges: 0.00
MBIO cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 23000.00
MBIO balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 9771000.00
MBIO balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 9771000.00
MBIO income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
MBIO income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.00
MBIO balance_sheet (quarterly, 2025-09-30) — Total Assets: 19361000.00
MBIO balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 9771000.00
MBIO balance_sheet (quarterly, 2025-09-30) — Total Debt: 0.00
MBIO balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 9771000.00
MBIO income_statement (quarterly, 2025-09-30) — Total Expenses: 624000.00
MBIO balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 9590000.00
MBIO balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 0.00
MBIO balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 150000.00
MBIO income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: -624000.00
MBIO income_statement (quarterly, 2025-09-30) — Total Unusual Items: 0.00
MBIO income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 0.00
MBIO balance_sheet (quarterly, 2025-09-30) — Working Capital: 9921000.00
MBIO income_statement (annual, 2025-12-31) — +Operating Expense: 2432000.00
MBIO income_statement (quarterly, 2025-12-31) — +Operating Expense: 670000.00
MBIO income_statement (annual, 2025-12-31) — +Total Revenue: 0.00
MBIO income_statement (quarterly, 2025-12-31) — +Total Revenue: 0.00
MBIO balance_sheet (annual, 2025-12-31) — Accounts Payable: 3510000.00
MBIO balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 3510000.00
MBIO balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 407899000.00
MBIO balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 407899000.00
MBIO cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 0.00
MBIO cash_flow (quarterly, 2025-12-31) — Asset Impairment Charge: 0.00
MBIO balance_sheet (annual, 2025-12-31) — Assets Held For Sale Current: 0.00
MBIO balance_sheet (quarterly, 2025-12-31) — Assets Held For Sale Current: 0.00
MBIO income_statement (annual, 2025-12-31) — Basic Average Shares: 4908164.00
MBIO income_statement (annual, 2025-12-31) — Basic EPS: -0.39
MBIO cash_flow (annual, 2025-12-31) — Beginning Cash Position: 6839000.00
MBIO cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 18984000.00
MBIO balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 0.00
MBIO balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 0.00
MBIO balance_sheet (annual, 2025-12-31) — Capital Stock: 1000.00
MBIO balance_sheet (quarterly, 2025-12-31) — Capital Stock: 1000.00
MBIO balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 17266000.00
MBIO balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 17266000.00
MBIO balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 17266000.00
MBIO balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 17266000.00
MBIO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 14526000.00
MBIO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 0.00
MBIO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: 1165000.00
MBIO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: 0.00
MBIO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: -5264000.00
MBIO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: -1718000.00
MBIO cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: -73000.00
MBIO cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: 0.00
MBIO cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: -2135000.00
MBIO cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: -795000.00
MBIO cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: 90000.00
MBIO cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: 50000.00
MBIO cash_flow (annual, 2025-12-31) — Change In Receivables: 435000.00
MBIO cash_flow (quarterly, 2025-12-31) — Change In Receivables: 0.00
MBIO cash_flow (annual, 2025-12-31) — Change In Working Capital: -1683000.00
MBIO cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -745000.00
MBIO cash_flow (annual, 2025-12-31) — Changes In Cash: 10427000.00
MBIO cash_flow (quarterly, 2025-12-31) — Changes In Cash: -1718000.00
MBIO balance_sheet (annual, 2025-12-31) — Common Stock: 1000.00
MBIO balance_sheet (quarterly, 2025-12-31) — Common Stock: 1000.00
MBIO balance_sheet (annual, 2025-12-31) — Common Stock Equity: 9529000.00
MBIO balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 9529000.00
MBIO cash_flow (annual, 2025-12-31) — Common Stock Issuance: 7381000.00
MBIO cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 0.00
MBIO balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 1877000.00
MBIO balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 1877000.00
MBIO balance_sheet (annual, 2025-12-31) — Current Assets: 17593000.00
MBIO balance_sheet (quarterly, 2025-12-31) — Current Assets: 17593000.00
MBIO balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 0.00
MBIO balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 0.00
MBIO balance_sheet (annual, 2025-12-31) — Current Liabilities: 7914000.00
MBIO balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 7914000.00
MBIO cash_flow (annual, 2025-12-31) — Depreciation: 41000.00
MBIO cash_flow (quarterly, 2025-12-31) — Depreciation: 0.00
MBIO cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 41000.00
MBIO cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 0.00
MBIO cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 41000.00
MBIO cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 0.00
MBIO income_statement (annual, 2025-12-31) — Diluted Average Shares: 4908164.00
MBIO income_statement (annual, 2025-12-31) — Diluted EPS: -0.39
MBIO income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -1921000.00
MBIO income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -538000.00
MBIO balance_sheet (annual, 2025-12-31) — Dueto Related Parties Current: 2503000.00
MBIO balance_sheet (quarterly, 2025-12-31) — Dueto Related Parties Current: 2503000.00
MBIO income_statement (annual, 2025-12-31) — EBIT: -2432000.00
MBIO income_statement (quarterly, 2025-12-31) — EBIT: -670000.00
MBIO income_statement (annual, 2025-12-31) — EBITDA: -2391000.00
MBIO income_statement (quarterly, 2025-12-31) — EBITDA: -670000.00
MBIO cash_flow (annual, 2025-12-31) — End Cash Position: 17266000.00
MBIO cash_flow (quarterly, 2025-12-31) — End Cash Position: 17266000.00
MBIO cash_flow (annual, 2025-12-31) — Financing Cash Flow: 14526000.00
MBIO cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 0.00
MBIO cash_flow (annual, 2025-12-31) — Free Cash Flow: -5264000.00
MBIO cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -1718000.00
MBIO cash_flow (annual, 2025-12-31) — Gain Loss On Sale Of PPE: 0.00
MBIO cash_flow (quarterly, 2025-12-31) — Gain Loss On Sale Of PPE: 0.00
MBIO income_statement (annual, 2025-12-31) — General And Administrative Expense: 3948000.00
MBIO income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 987000.00
MBIO balance_sheet (annual, 2025-12-31) — Gross PPE: 0.00
MBIO balance_sheet (quarterly, 2025-12-31) — Gross PPE: 0.00
MBIO income_statement (annual, 2025-12-31) — Impairment Of Capital Assets: 0.00
MBIO income_statement (quarterly, 2025-12-31) — Impairment Of Capital Assets: 0.00
MBIO income_statement (annual, 2025-12-31) — Interest Income: 511000.00
MBIO income_statement (quarterly, 2025-12-31) — Interest Income: 132000.00
MBIO income_statement (annual, 2025-12-31) — Interest Income Non Operating: 511000.00
MBIO income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 132000.00
MBIO balance_sheet (annual, 2025-12-31) — Invested Capital: 9529000.00
MBIO balance_sheet (quarterly, 2025-12-31) — Invested Capital: 9529000.00
MBIO cash_flow (annual, 2025-12-31) — Investing Cash Flow: 1165000.00
MBIO cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: 0.00
MBIO cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 7381000.00
MBIO cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: 0.00
MBIO balance_sheet (annual, 2025-12-31) — Leases: 0.00
MBIO balance_sheet (quarterly, 2025-12-31) — Leases: 0.00
MBIO balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 0.00
MBIO balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 0.00
MBIO balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 0.00
MBIO balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 0.00
MBIO cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 7381000.00
MBIO cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: 0.00
MBIO income_statement (annual, 2025-12-31) — Net Income: -1921000.00
MBIO income_statement (quarterly, 2025-12-31) — Net Income: -538000.00
MBIO income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -1921000.00
MBIO income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -538000.00
MBIO income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -1921000.00
MBIO income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -538000.00
MBIO income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -1921000.00
MBIO income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -538000.00
MBIO income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -1921000.00
MBIO income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -538000.00
MBIO cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -1921000.00
MBIO cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -538000.00
MBIO income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -1921000.00
MBIO income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -538000.00
MBIO income_statement (annual, 2025-12-31) — Net Interest Income: 511000.00
MBIO income_statement (quarterly, 2025-12-31) — Net Interest Income: 132000.00
MBIO income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: 511000.00
MBIO income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: 132000.00
MBIO balance_sheet (annual, 2025-12-31) — Net PPE: 0.00
MBIO balance_sheet (quarterly, 2025-12-31) — Net PPE: 0.00
MBIO cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: 1165000.00
MBIO cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: 0.00
MBIO balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 9529000.00
MBIO balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 9529000.00
MBIO balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 150000.00
MBIO balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 150000.00
MBIO balance_sheet (annual, 2025-12-31) — Non Current Deferred Revenue: 150000.00
MBIO balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Revenue: 150000.00
MBIO income_statement (annual, 2025-12-31) — Normalized EBITDA: -2391000.00
MBIO income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -670000.00
MBIO income_statement (annual, 2025-12-31) — Normalized Income: -1921000.00
MBIO income_statement (quarterly, 2025-12-31) — Normalized Income: -538000.00
MBIO cash_flow (annual, 2025-12-31) — Operating Cash Flow: -5264000.00
MBIO cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: -1718000.00
MBIO income_statement (annual, 2025-12-31) — Operating Income: -2432000.00
MBIO income_statement (quarterly, 2025-12-31) — Operating Income: -670000.00
MBIO income_statement (annual, 2025-12-31) — Operating Revenue: 0.00
MBIO income_statement (quarterly, 2025-12-31) — Operating Revenue: 0.00
MBIO balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 7299086.00
MBIO balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 7299086.00
MBIO balance_sheet (annual, 2025-12-31) — Other Current Assets: 110000.00
MBIO balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 110000.00
MBIO balance_sheet (annual, 2025-12-31) — Other Equity Interest: 273000.00
MBIO balance_sheet (quarterly, 2025-12-31) — Other Equity Interest: 273000.00
MBIO income_statement (annual, 2025-12-31) — Other Gand A: 3948000.00
MBIO income_statement (quarterly, 2025-12-31) — Other Gand A: 987000.00
MBIO cash_flow (annual, 2025-12-31) — Other Non Cash Items: -1830000.00
MBIO cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: -458000.00
MBIO balance_sheet (annual, 2025-12-31) — Other Receivables: 217000.00
MBIO balance_sheet (quarterly, 2025-12-31) — Other Receivables: 217000.00
MBIO balance_sheet (annual, 2025-12-31) — Payables: 6013000.00
MBIO balance_sheet (quarterly, 2025-12-31) — Payables: 6013000.00
MBIO balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 7890000.00
MBIO balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 7890000.00
MBIO balance_sheet (annual, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 24000.00
MBIO balance_sheet (quarterly, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 24000.00
MBIO balance_sheet (annual, 2025-12-31) — Preferred Shares Number: 250000.00
MBIO balance_sheet (quarterly, 2025-12-31) — Preferred Shares Number: 250000.00
MBIO balance_sheet (annual, 2025-12-31) — Preferred Stock: 0.00
MBIO balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 0.00
MBIO income_statement (annual, 2025-12-31) — Pretax Income: -1921000.00
MBIO income_statement (quarterly, 2025-12-31) — Pretax Income: -538000.00
MBIO cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: 7145000.00
MBIO cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: 0.00
MBIO balance_sheet (annual, 2025-12-31) — Properties: 0.00
MBIO balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
MBIO balance_sheet (annual, 2025-12-31) — Receivables: 217000.00
MBIO balance_sheet (quarterly, 2025-12-31) — Receivables: 217000.00
MBIO income_statement (annual, 2025-12-31) — Reconciled Depreciation: 41000.00
MBIO income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 0.00
MBIO income_statement (annual, 2025-12-31) — Research And Development: -1516000.00
MBIO income_statement (quarterly, 2025-12-31) — Research And Development: -317000.00
MBIO balance_sheet (annual, 2025-12-31) — Retained Earnings: -398644000.00
MBIO balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -398644000.00
MBIO cash_flow (annual, 2025-12-31) — Sale Of PPE: 1165000.00
MBIO cash_flow (quarterly, 2025-12-31) — Sale Of PPE: 0.00
MBIO income_statement (annual, 2025-12-31) — Selling General And Administration: 3948000.00
MBIO income_statement (quarterly, 2025-12-31) — Selling General And Administration: 987000.00
MBIO balance_sheet (annual, 2025-12-31) — Share Issued: 7299086.00
MBIO balance_sheet (quarterly, 2025-12-31) — Share Issued: 7299086.00
MBIO income_statement (annual, 2025-12-31) — Special Income Charges: 0.00
MBIO income_statement (quarterly, 2025-12-31) — Special Income Charges: 0.00
MBIO cash_flow (annual, 2025-12-31) — Stock Based Compensation: 129000.00
MBIO cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 23000.00
MBIO balance_sheet (annual, 2025-12-31) — Stockholders Equity: 9529000.00
MBIO balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 9529000.00
MBIO balance_sheet (annual, 2025-12-31) — Tangible Book Value: 9529000.00
MBIO balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 9529000.00
MBIO income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
MBIO income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
MBIO income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.01
MBIO income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.00
MBIO balance_sheet (annual, 2025-12-31) — Total Assets: 17593000.00
MBIO balance_sheet (quarterly, 2025-12-31) — Total Assets: 17593000.00
MBIO balance_sheet (annual, 2025-12-31) — Total Capitalization: 9529000.00
MBIO balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 9529000.00
MBIO balance_sheet (annual, 2025-12-31) — Total Debt: 0.00
MBIO balance_sheet (quarterly, 2025-12-31) — Total Debt: 0.00
MBIO balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 9529000.00
MBIO balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 9529000.00
MBIO income_statement (annual, 2025-12-31) — Total Expenses: 2432000.00
MBIO income_statement (quarterly, 2025-12-31) — Total Expenses: 670000.00
MBIO balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 8064000.00
MBIO balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 8064000.00
MBIO balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 0.00
MBIO balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 0.00
MBIO balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 150000.00
MBIO balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 150000.00
MBIO income_statement (annual, 2025-12-31) — Total Operating Income As Reported: -2432000.00
MBIO income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: -670000.00
MBIO income_statement (annual, 2025-12-31) — Total Unusual Items: 0.00
MBIO income_statement (quarterly, 2025-12-31) — Total Unusual Items: 0.00
MBIO income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: 0.00
MBIO income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: 0.00
MBIO balance_sheet (annual, 2025-12-31) — Working Capital: 9679000.00
MBIO balance_sheet (quarterly, 2025-12-31) — Working Capital: 9679000.00
MBIO income_statement (quarterly, 2026-03-31) — +Operating Expense: 1058000.00
MBIO income_statement (quarterly, 2026-03-31) — +Total Revenue: 0.00
MBIO balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 3341000.00
MBIO balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 408194000.00
MBIO income_statement (quarterly, 2026-03-31) — Basic Average Shares: 6729855.00
MBIO income_statement (quarterly, 2026-03-31) — Basic EPS: -0.14
MBIO cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 17266000.00
MBIO balance_sheet (quarterly, 2026-03-31) — Capital Stock: 1000.00
MBIO balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 16258000.00
MBIO balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 16258000.00
MBIO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: 0.00
MBIO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: 0.00
MBIO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -1008000.00
MBIO cash_flow (quarterly, 2026-03-31) — Change In Other Current Liabilities: 0.00
MBIO cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -2000.00
MBIO cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: 3000.00
MBIO cash_flow (quarterly, 2026-03-31) — Change In Receivables: 0.00
MBIO cash_flow (quarterly, 2026-03-31) — Change In Working Capital: 1000.00
MBIO cash_flow (quarterly, 2026-03-31) — Changes In Cash: -1008000.00
MBIO balance_sheet (quarterly, 2026-03-31) — Common Stock: 1000.00
MBIO balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 8596000.00
MBIO cash_flow (quarterly, 2026-03-31) — Common Stock Issuance: 0.00
MBIO balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 1814000.00
MBIO balance_sheet (quarterly, 2026-03-31) — Current Assets: 16582000.00
MBIO balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 7836000.00
MBIO cash_flow (quarterly, 2026-03-31) — Depreciation: 0.00
MBIO cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 0.00
MBIO cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 0.00
MBIO income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 6729855.00
MBIO income_statement (quarterly, 2026-03-31) — Diluted EPS: -0.14
MBIO income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -955000.00
MBIO balance_sheet (quarterly, 2026-03-31) — Dueto Related Parties Current: 2521000.00
MBIO income_statement (quarterly, 2026-03-31) — EBIT: -1058000.00
MBIO income_statement (quarterly, 2026-03-31) — EBITDA: -1058000.00
MBIO cash_flow (quarterly, 2026-03-31) — End Cash Position: 16258000.00
MBIO cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: 0.00
MBIO cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -1008000.00
MBIO income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 880000.00
MBIO income_statement (quarterly, 2026-03-31) — Interest Income: 103000.00
MBIO income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 103000.00
MBIO balance_sheet (quarterly, 2026-03-31) — Invested Capital: 8596000.00
MBIO cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: 0.00
MBIO cash_flow (quarterly, 2026-03-31) — Issuance Of Capital Stock: 0.00
MBIO cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: 0.00
MBIO income_statement (quarterly, 2026-03-31) — Net Income: -955000.00
MBIO income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -955000.00
MBIO income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -955000.00
MBIO income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -955000.00
MBIO income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -955000.00
MBIO cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: -955000.00
MBIO income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -955000.00
MBIO income_statement (quarterly, 2026-03-31) — Net Interest Income: 103000.00
MBIO income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: 103000.00
MBIO cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: 0.00
MBIO balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 8596000.00
MBIO balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 150000.00
MBIO balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Revenue: 150000.00
MBIO income_statement (quarterly, 2026-03-31) — Normalized EBITDA: -1058000.00
MBIO income_statement (quarterly, 2026-03-31) — Normalized Income: -955000.00
MBIO cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -1008000.00
MBIO income_statement (quarterly, 2026-03-31) — Operating Income: -1058000.00
MBIO income_statement (quarterly, 2026-03-31) — Operating Revenue: 0.00
MBIO balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 7577477.00
MBIO balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 107000.00
MBIO income_statement (quarterly, 2026-03-31) — Other Gand A: 880000.00
MBIO cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: -76000.00
MBIO balance_sheet (quarterly, 2026-03-31) — Other Receivables: 217000.00
MBIO balance_sheet (quarterly, 2026-03-31) — Payables: 5862000.00
MBIO balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 7676000.00
MBIO balance_sheet (quarterly, 2026-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 160000.00
MBIO balance_sheet (quarterly, 2026-03-31) — Preferred Shares Number: 250000.00
MBIO balance_sheet (quarterly, 2026-03-31) — Preferred Stock: 0.00
MBIO income_statement (quarterly, 2026-03-31) — Pretax Income: -955000.00
MBIO balance_sheet (quarterly, 2026-03-31) — Receivables: 217000.00
MBIO income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 0.00
MBIO income_statement (quarterly, 2026-03-31) — Research And Development: 178000.00
MBIO balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -399599000.00
MBIO cash_flow (quarterly, 2026-03-31) — Sale Of PPE: 0.00
MBIO income_statement (quarterly, 2026-03-31) — Selling General And Administration: 880000.00
MBIO balance_sheet (quarterly, 2026-03-31) — Share Issued: 7577477.00
MBIO cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 22000.00
MBIO balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 8596000.00
MBIO balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 8596000.00
MBIO income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
MBIO income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.00
MBIO balance_sheet (quarterly, 2026-03-31) — Total Assets: 16582000.00
MBIO balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 8596000.00
MBIO balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 8596000.00
MBIO income_statement (quarterly, 2026-03-31) — Total Expenses: 1058000.00
MBIO balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 7986000.00
MBIO balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 0.00
MBIO balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 150000.00
MBIO income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: -1058000.00
MBIO balance_sheet (quarterly, 2026-03-31) — Working Capital: 8746000.00
MBK.AX income_statement (annual, 2021-06-30) — +Operating Expense: 473982.00
MBK.AX balance_sheet (annual, 2021-06-30) — Accounts Payable: 96236.00
MBK.AX balance_sheet (annual, 2021-06-30) — Accumulated Depreciation: -16660.00
MBK.AX income_statement (annual, 2021-06-30) — Basic Average Shares: 127807652.00
MBK.AX income_statement (annual, 2021-06-30) — Basic EPS: 0.00
MBK.AX cash_flow (annual, 2021-06-30) — Beginning Cash Position: 627052.00
MBK.AX cash_flow (annual, 2021-06-30) — Capital Expenditure: -1593849.00
MBK.AX cash_flow (annual, 2021-06-30) — Capital Expenditure Reported: -1593849.00
MBK.AX balance_sheet (annual, 2021-06-30) — Capital Stock: 22879168.00
MBK.AX balance_sheet (annual, 2021-06-30) — Cash And Cash Equivalents: 1000615.00
MBK.AX balance_sheet (annual, 2021-06-30) — Cash Cash Equivalents And Short Term Investments: 1001865.00
MBK.AX balance_sheet (annual, 2021-06-30) — Cash Financial: 1000615.00
MBK.AX cash_flow (annual, 2021-06-30) — Cash Flow From Continuing Financing Activities: 2046266.00
MBK.AX cash_flow (annual, 2021-06-30) — Cash Flow From Continuing Investing Activities: -1193849.00
MBK.AX cash_flow (annual, 2021-06-30) — Cash Flowsfromusedin Operating Activities Direct: -478854.00
MBK.AX cash_flow (annual, 2021-06-30) — Changes In Cash: 373563.00
MBK.AX cash_flow (annual, 2021-06-30) — Classesof Cash Payments: -585130.00
MBK.AX cash_flow (annual, 2021-06-30) — Classesof Cash Receiptsfrom Operating Activities: 106000.00
MBK.AX balance_sheet (annual, 2021-06-30) — Common Stock: 22879168.00
MBK.AX balance_sheet (annual, 2021-06-30) — Common Stock Equity: 10801996.00
MBK.AX cash_flow (annual, 2021-06-30) — Common Stock Issuance: 2111512.00
MBK.AX cash_flow (annual, 2021-06-30) — Common Stock Payments: -65246.00
MBK.AX balance_sheet (annual, 2021-06-30) — Current Assets: 1135603.00
MBK.AX balance_sheet (annual, 2021-06-30) — Current Liabilities: 166234.00
MBK.AX income_statement (annual, 2021-06-30) — Depreciation Amortization Depletion Income Statement: 3270.00
MBK.AX income_statement (annual, 2021-06-30) — Depreciation And Amortization In Income Statement: 3270.00
MBK.AX income_statement (annual, 2021-06-30) — Depreciation Income Statement: 3270.00
MBK.AX income_statement (annual, 2021-06-30) — Diluted Average Shares: 127807652.00
MBK.AX income_statement (annual, 2021-06-30) — Diluted EPS: 0.00
MBK.AX income_statement (annual, 2021-06-30) — EBIT: -473982.00
MBK.AX income_statement (annual, 2021-06-30) — EBITDA: -470712.00
MBK.AX cash_flow (annual, 2021-06-30) — End Cash Position: 1000615.00
MBK.AX cash_flow (annual, 2021-06-30) — Financing Cash Flow: 2046266.00
MBK.AX cash_flow (annual, 2021-06-30) — Free Cash Flow: -2072703.00
MBK.AX balance_sheet (annual, 2021-06-30) — Gains Losses Not Affecting Retained Earnings: 54180.00
MBK.AX income_statement (annual, 2021-06-30) — General And Administrative Expense: 216383.00
MBK.AX balance_sheet (annual, 2021-06-30) — Gross PPE: 3849287.00
MBK.AX income_statement (annual, 2021-06-30) — Interest Income: 276.00
MBK.AX income_statement (annual, 2021-06-30) — Interest Income Non Operating: 276.00
MBK.AX cash_flow (annual, 2021-06-30) — Interest Received Direct: 276.00
MBK.AX balance_sheet (annual, 2021-06-30) — Invested Capital: 10801996.00
MBK.AX cash_flow (annual, 2021-06-30) — Investing Cash Flow: -1193849.00
MBK.AX cash_flow (annual, 2021-06-30) — Issuance Of Capital Stock: 2111512.00
MBK.AX balance_sheet (annual, 2021-06-30) — Machinery Furniture Equipment: 19983.00
MBK.AX cash_flow (annual, 2021-06-30) — Net Common Stock Issuance: 2046266.00
MBK.AX income_statement (annual, 2021-06-30) — Net Income: -364436.00
MBK.AX income_statement (annual, 2021-06-30) — Net Income Common Stockholders: -364436.00
MBK.AX income_statement (annual, 2021-06-30) — Net Income Continuous Operations: -364436.00
MBK.AX income_statement (annual, 2021-06-30) — Net Income From Continuing And Discontinued Operation: -364436.00
MBK.AX income_statement (annual, 2021-06-30) — Net Income From Continuing Operation Net Minority Interest: -364436.00
MBK.AX income_statement (annual, 2021-06-30) — Net Income Including Noncontrolling Interests: -364436.00
MBK.AX income_statement (annual, 2021-06-30) — Net Interest Income: 276.00
MBK.AX cash_flow (annual, 2021-06-30) — Net Investment Purchase And Sale: 400000.00
MBK.AX income_statement (annual, 2021-06-30) — Net Non Operating Interest Income Expense: 276.00
MBK.AX balance_sheet (annual, 2021-06-30) — Net PPE: 3832627.00
MBK.AX balance_sheet (annual, 2021-06-30) — Net Tangible Assets: 10801996.00
MBK.AX income_statement (annual, 2021-06-30) — Normalized EBITDA: -470712.00
MBK.AX income_statement (annual, 2021-06-30) — Normalized Income: -364436.00
MBK.AX income_statement (annual, 2021-06-30) — Operating Income: -473982.00
MBK.AX balance_sheet (annual, 2021-06-30) — Ordinary Shares Number: 133486866.00
MBK.AX cash_flow (annual, 2021-06-30) — Other Cash Receiptsfrom Operating Activities: 106000.00
MBK.AX balance_sheet (annual, 2021-06-30) — Other Equity Adjustments: 54180.00
MBK.AX income_statement (annual, 2021-06-30) — Other Gand A: 105090.00
MBK.AX income_statement (annual, 2021-06-30) — Other Income Expense: 106000.00
MBK.AX balance_sheet (annual, 2021-06-30) — Other Non Current Assets: 6000000.00
MBK.AX income_statement (annual, 2021-06-30) — Other Non Operating Income Expenses: 106000.00
MBK.AX income_statement (annual, 2021-06-30) — Other Operating Expenses: 254329.00
MBK.AX balance_sheet (annual, 2021-06-30) — Other Payable: 69998.00
MBK.AX balance_sheet (annual, 2021-06-30) — Other Properties: 3829304.00
MBK.AX balance_sheet (annual, 2021-06-30) — Other Receivables: 133738.00
MBK.AX balance_sheet (annual, 2021-06-30) — Other Short Term Investments: 1250.00
MBK.AX balance_sheet (annual, 2021-06-30) — Payables: 166234.00
MBK.AX balance_sheet (annual, 2021-06-30) — Payables And Accrued Expenses: 166234.00
MBK.AX cash_flow (annual, 2021-06-30) — Paymentsto Suppliersfor Goodsand Services: -585130.00
MBK.AX income_statement (annual, 2021-06-30) — Pretax Income: -364436.00
MBK.AX balance_sheet (annual, 2021-06-30) — Receivables: 133738.00
MBK.AX income_statement (annual, 2021-06-30) — Reconciled Depreciation: 3270.00
MBK.AX cash_flow (annual, 2021-06-30) — Repurchase Of Capital Stock: -65246.00
MBK.AX balance_sheet (annual, 2021-06-30) — Retained Earnings: -12131352.00
MBK.AX income_statement (annual, 2021-06-30) — Salaries And Wages: 111293.00
MBK.AX cash_flow (annual, 2021-06-30) — Sale Of Investment: 400000.00
MBK.AX income_statement (annual, 2021-06-30) — Selling General And Administration: 216383.00
MBK.AX balance_sheet (annual, 2021-06-30) — Share Issued: 133486866.00
MBK.AX balance_sheet (annual, 2021-06-30) — Stockholders Equity: 10801996.00
MBK.AX balance_sheet (annual, 2021-06-30) — Tangible Book Value: 10801996.00
MBK.AX income_statement (annual, 2021-06-30) — Tax Effect Of Unusual Items: 0.00
MBK.AX income_statement (annual, 2021-06-30) — Tax Provision: 0.00
MBK.AX income_statement (annual, 2021-06-30) — Tax Rate For Calcs: 0.00
MBK.AX balance_sheet (annual, 2021-06-30) — Total Assets: 10968230.00
MBK.AX balance_sheet (annual, 2021-06-30) — Total Capitalization: 10801996.00
MBK.AX balance_sheet (annual, 2021-06-30) — Total Equity Gross Minority Interest: 10801996.00
MBK.AX balance_sheet (annual, 2021-06-30) — Total Liabilities Net Minority Interest: 166234.00
MBK.AX balance_sheet (annual, 2021-06-30) — Total Non Current Assets: 9832627.00
MBK.AX balance_sheet (annual, 2021-06-30) — Total Non Current Liabilities Net Minority Interest: 0.00
MBK.AX balance_sheet (annual, 2021-06-30) — Working Capital: 969369.00
MBK.AX income_statement (annual, 2022-06-30) — +Operating Expense: 1896028.00
MBK.AX balance_sheet (annual, 2022-06-30) — Accounts Payable: 627671.00
MBK.AX balance_sheet (annual, 2022-06-30) — Accumulated Depreciation: -18603.00
MBK.AX income_statement (annual, 2022-06-30) — Basic Average Shares: 211781174.00
MBK.AX income_statement (annual, 2022-06-30) — Basic EPS: -0.01
MBK.AX cash_flow (annual, 2022-06-30) — Beginning Cash Position: 1000615.00
MBK.AX cash_flow (annual, 2022-06-30) — Capital Expenditure: -1049709.00
MBK.AX cash_flow (annual, 2022-06-30) — Capital Expenditure Reported: -1049709.00
MBK.AX balance_sheet (annual, 2022-06-30) — Capital Stock: 33715336.00
MBK.AX balance_sheet (annual, 2022-06-30) — Cash And Cash Equivalents: 5689880.00
MBK.AX balance_sheet (annual, 2022-06-30) — Cash Cash Equivalents And Short Term Investments: 5691130.00
MBK.AX balance_sheet (annual, 2022-06-30) — Cash Financial: 5689880.00
MBK.AX cash_flow (annual, 2022-06-30) — Cash Flow From Continuing Financing Activities: 9629668.00
MBK.AX cash_flow (annual, 2022-06-30) — Cash Flow From Continuing Investing Activities: -3549709.00
MBK.AX cash_flow (annual, 2022-06-30) — Cash Flowsfromusedin Operating Activities Direct: -1390694.00
MBK.AX cash_flow (annual, 2022-06-30) — Changes In Cash: 4689265.00
MBK.AX cash_flow (annual, 2022-06-30) — Classesof Cash Payments: -1391529.00
MBK.AX balance_sheet (annual, 2022-06-30) — Common Stock: 33715336.00
MBK.AX balance_sheet (annual, 2022-06-30) — Common Stock Equity: 20342408.00
MBK.AX cash_flow (annual, 2022-06-30) — Common Stock Issuance: 10100000.00
MBK.AX cash_flow (annual, 2022-06-30) — Common Stock Payments: -470332.00
MBK.AX balance_sheet (annual, 2022-06-30) — Current Assets: 5826830.00
MBK.AX balance_sheet (annual, 2022-06-30) — Current Liabilities: 2289935.00
MBK.AX income_statement (annual, 2022-06-30) — Depreciation Amortization Depletion Income Statement: 1943.00
MBK.AX income_statement (annual, 2022-06-30) — Depreciation And Amortization In Income Statement: 1943.00
MBK.AX income_statement (annual, 2022-06-30) — Depreciation Income Statement: 1943.00
MBK.AX income_statement (annual, 2022-06-30) — Diluted Average Shares: 211781174.00
MBK.AX income_statement (annual, 2022-06-30) — Diluted EPS: -0.01
MBK.AX income_statement (annual, 2022-06-30) — EBIT: -1896028.00
MBK.AX income_statement (annual, 2022-06-30) — EBITDA: -1894085.00
MBK.AX cash_flow (annual, 2022-06-30) — End Cash Position: 5689880.00
MBK.AX cash_flow (annual, 2022-06-30) — Financing Cash Flow: 9629668.00
MBK.AX cash_flow (annual, 2022-06-30) — Free Cash Flow: -2440403.00
MBK.AX balance_sheet (annual, 2022-06-30) — Gains Losses Not Affecting Retained Earnings: 597494.00
MBK.AX income_statement (annual, 2022-06-30) — General And Administrative Expense: 824805.00
MBK.AX balance_sheet (annual, 2022-06-30) — Gross PPE: 10824116.00
MBK.AX income_statement (annual, 2022-06-30) — Interest Income: 835.00
MBK.AX income_statement (annual, 2022-06-30) — Interest Income Non Operating: 835.00
MBK.AX cash_flow (annual, 2022-06-30) — Interest Received Direct: 835.00
MBK.AX balance_sheet (annual, 2022-06-30) — Invested Capital: 20342408.00
MBK.AX cash_flow (annual, 2022-06-30) — Investing Cash Flow: -3549709.00
MBK.AX cash_flow (annual, 2022-06-30) — Issuance Of Capital Stock: 10100000.00
MBK.AX balance_sheet (annual, 2022-06-30) — Machinery Furniture Equipment: 19983.00
MBK.AX cash_flow (annual, 2022-06-30) — Net Common Stock Issuance: 9629668.00
MBK.AX income_statement (annual, 2022-06-30) — Net Income: -1893250.00